Ganzhou Hemay Pharmaceutical Co., Ltd
Quick facts
Phase 3 pipeline
- Hemay005 · Oncology
Hemay005 is a small molecule inhibitor targeting a specific kinase involved in cancer cell proliferation and survival.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: